New tris(dopamine) derivative as an iron chelator. Synthesis, solution thermodynamic stability, and antioxidant research.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Inorganic Biochemistry

• Publication date

  2017-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jinorgbio.2017.03.003PMID 28364616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Building on 50 years of levodopa therapy.

  2016cited by this paper
• Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: design, synthesis and inhibition on methicillin resistant Staphylococcus aureus and Pseudomonas strains.

  2015cited by this paper
• Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators.

  2015cited by this paper
• Neurodegenerative diseases and therapeutic strategies using iron chelators.

  2015cited by this paper
• Deferitazole, a new orally active iron chelator.

  2015cited by this paper
• Mode of iron(III) chelation by hexadentate hydroxypyridinones.

  2015cited by this paper
• Design, synthesis and biological evaluation of peptide derivatives of L-dopa as anti-parkinsonian agents.

  2013cited by this paper
• Design of iron chelators with therapeutic application.

  2012cited by this paper
• Design, synthesis and biological evaluation of L-dopa amide derivatives as potential prodrugs for the treatment of Parkinson's disease.

  2010cited by this paper
• Amido-3-hydroxypyridin-4-ones as iron(III) ligands.

  2010cited by this paper
• Synergistic antioxidant and antibacterial activity of rosemary plus butylated derivatives

  2009cited by this paper
• DPPH antioxidant assay revisited

  2009cited by this paper
• Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation.

  2009cited by this paper
• Homo-and heterodinuclear complexes of the tris(catecholamide) derivative of a tetraazamacrocycle with Fe3+, Cu2+ and Zn2+ metal ions.

  2008cited by this paper
• Iron chelating agents for the treatment of iron overload

  2008cited by this paper
• COMPARATIVE EVALUATION OF THE ANTIOXIDANT CAPACITY OF SMOKE FLAVOURING PHENOLS BY CROCIN BLEACHING INHIBITION, DPPH RADICAL SCAVENGING AND OXIDATION POTENTIAL

  2007cited by this paper
• Fe(III)-coordination properties of neuromelanin components: 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid.

  2006cited by this paper
• An Akt /-Arrestin 2 / PP 2 A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior

  2005cited by this paper
• Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.

  2005cited by this paper
• Novel potential neuroprotective agents with both iron chelating and amino acid-based derivatives targeting central nervous system neurons.

  2005cited by this paper
• Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition

  2005cited by this paper
• High affinity iron(III) scavenging by a novel hexadentate 3-hydroxypyridin-4-one-based dendrimer: synthesis and characterization.

  2005cited by this paper
• Electron-transfer reaction of cinnamic acids and their methyl esters with the DPPH(*) radical in alcoholic solutions.

  2004cited by this paper
• Iron, brain ageing and neurodegenerative disorders

  2004cited by this paper
• Visible absorption spectra of metal-catecholate and metal-tironate complexes.

  2004cited by this paper
• Comparative studies on the iron chelators O-TRENSOX and TRENCAMS: selectivity of the complexation towards other biologically relevant metal ions and Al(3+).

  2002cited by this paper
• Hexadentate hydroxypyridonate iron chelators based on TREN-Me-3,2-HOPO: variation of cap size.

  2002cited by this paper
• Oral iron chelators--development and application.

  2002cited by this paper
• Structural criteria for the rational design of selective ligands. 3. Quantitative structure-stability relationship for iron(III) complexation by tris-catecholamide siderophores.

  2001cited by this paper
• New therapies for Parkinson's disease

  2001cited by this paper
• Brain iron pathways and their relevance to Parkinson's disease.

  2001cited by this paper
• Brain iron pathways and their relevance to Parkinson's disease

  2001cited by this paper
• Synthesis and iron(III) complexing ability of CacCAM, a new analog of enterobactin possessing a free carboxylic anchor arm. Comparative studies with TRENCAM

  2000cited by this paper
• Hyperquad simulation and speciation (HySS): a utility program for the investigation of equilibria involving soluble and partially soluble species

  1999cited by this paper
• Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.

  1999cited by this paper
• A procedure to measure the antiradical efficiency of polyphenols

  1998cited by this paper
• DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.

  1998cited by this paper
• Synthetic and structural studies of linear bis-catechol amide, N,N{prime}-bis(2,3-dihydroxybenzoyl)-1,7-diazaheptane (5-LICAM), and its complexes with Ni{sup 2+} and Co{sup 2+}: Utilization of a polymer-supported, sulfonated analog, 5-LICAMS, as a biomimetic ligand for divalent metal ion removal fro

  1995cited by this paper
• Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxyl-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium(IV) chelation.

  1995cited by this paper
• Siderophores: Structure and Function of Microbial Iron Transport Compounds (*)

  1995cited by this paper
• Phenolic antioxidants.

  1992cited by this paper
• Comparison of the Antioxidative Activity of Some Acid-phenols: Structure-Activity Relationship.

  1992cited by this paper
• Solution equilibria of enterobactin and metal-enterobactin complexes

  1991cited by this paper
• Actinide-specific complexing agents: their structural and solution chemistry

  1983cited by this paper
• Ferric ion sequestering agents. 10. Selectivity of sulfonated poly(catechoylamides) for ferric ion

  1982cited by this paper
• Theoretical study of o-quinone complexes of iron

  1982cited by this paper
• COORDINATION CHEMISTRY OF MICROBIAL IRON TRANSPORT COMPOUNDS. 19. STABILITY CONSTANTS AND ELECTROCHEMICAL BEHAVIOR OF FERRIC ENTEROBACTIN AND MODEL COMPLEXES

  1979cited by this paper
• Ferric ion sequestering agents. 3. The spectrophotometric and potentiometric evaluation of two new enterobactin analogs: 1,5,9-N,N',N''-tris(2,3-dihydroxybenzoyl)cyclotriazatridecane and 1,3,5-N,N',N''-tris(2,3-dihydroxybenzoyl)triaminomethylbenzene

  1979cited by this paper
• Ferric ion sequestering agents. 1. Hexadentate O-bonding N,N',N"-tris(2,3-dihydroxybenzoyl) derivatives of 1,5,9-triazacyclotridecane and 1,3,5-triaminomethylbenzene

  1979cited by this paper
• Coordination chemistry of microbial iron transport compounds. 13. Preparation and chirality of the rhodium(III) enterobactin complex and model tris(catecholato)rhodate(III) analogs

  1978cited by this paper
• Coordination isomers of biological iron transport compounds. V. The preparation and chirality of the chromium(III) enterobactin complex and model tris(catechol)chromium(III) analogues.

  1976cited by this paper
• Dopamine as a possible neurotransmitter in gastric relaxation.

  1976cited by this paper
• Reassessment of the use of desferrioxamine B in iron overload.

  1976cited by this paper
• Biologically active compounds containing 2,3-dihydroxybenzoic acid and serine formed by Escherichia coli.

  1970cited by this paper

• Flow reactor-based batch production of direct radiolabelable superparamagnetic iron oxide for PET/MRI dual-modality contrast agent

  2025cites this paper
• Therapeutic Potential of Dopamine and Related Drugs as Anti-Inflammatories and Antioxidants in Neuronal and Non-Neuronal Pathologies

  2023cites this paper
• Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities

  2022cites this paper
• Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies

  2021cites this paper
• Characterization of the binding affinity between some anti-Parkinson agents and Mn2+, Fe3+ and Zn2+ metal ions: A DFT insight

  2021cites this paper
• Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.

  2021cites this paper
• Metals and Metal-Nanoparticles in Human Pathologies: From Exposure to Therapy

  2021cites this paper
• New hexadentate tris(dopamine) as iron chelating agent: Synthesis, solution thermodynamic stability and antioxidant activity studies

  2019cites this paper
• Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments

  2019cites this paper
• Hexadentate β-Dicarbonyl(bis-catecholamine) Ligands for Efficient Uranyl Cation Decorporation: Thermodynamic and Antioxidant Activity Studies.

  2019cites this paper
• Coprecipitation Preparation of Cu/Zn/Al-Hydrotalcite-Like Compound for Copper Removal from Electroplating Wastewater

  2019cites this paper
• Role of purines on the copper-catalyzed oxidative damage in biological systems: Protection versus promotion

  2018cites this paper
• Synthesis of a Photo‐Caged DOPA Derivative by Selective Alkylation of 3,4‐Dihydroxybenzaldehyde

  2018cites this paper
• The mono(catecholamine) derivatives as iron chelators: synthesis, solution thermodynamic stability and antioxidant properties research

  2018influential citation